Dexcom (DXCM) Profit After Tax Growth (5y) (2015 - 2026)
Powered by 
Analysis
Dexcom (DXCM) Profit After Tax Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 178.25 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn |
| 3 | Medtronic | 118.18 Bn | 109.36 Bn | 6.34 Bn |
| 4 | Stryker | 104.54 Bn | 101.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.34 Bn | 65.80 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.64 Bn | 45.39 Bn | 1.35 Bn |
| 7 | Alcon | 33.93 Bn | 32.47 Bn | 1.68 Bn |
| 8 | Dexcom | 32.20 Bn | 30.25 Bn | 830.00 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.11 Bn | 17.70 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.01% |
| Mar 31, 2026 | 28.70% |
| Dec 31, 2025 | -8.26% |
| Sep 30, 2025 | 31.49% |
| Jun 30, 2025 | 31.17% |
| Mar 31, 2025 | 39.57% |
| Dec 31, 2024 | 10.35% |
| Sep 30, 2024 | 24.06% |
| Jun 30, 2024 | 73.38% |
| Mar 31, 2024 | 49.40% |
| Dec 31, 2023 | 27.93% |
| Sep 30, 2023 | 20.97% |
| Jun 30, 2023 | 30.86% |
| Mar 31, 2023 | 32.01% |
| Dec 31, 2022 | 63.73% |
| Sep 30, 2022 | 120.90% |
| Jun 30, 2022 | 77.36% |
| Mar 31, 2022 | 34.08% |
| Dec 31, 2021 | 6.46% |
| Sep 30, 2021 | 46.04% |